2013
DOI: 10.1002/iub.1147
|View full text |Cite
|
Sign up to set email alerts
|

Mitochondria as a pharmacological target: Magnum overview

Abstract: Mitochondria, responsible for energy metabolism within the cell, act as signaling organelles. Mitochondrial dysfunction may lead to cell death and oxidative stress and may disturb calcium metabolism. Additionally, mitochondria play a pivotal role in cardioprotective phenomena and a variety of neurodegenerative disorders ranging from Parkinson's to Alzheimer's disease. Mitochondrial DNA mutations may lead to impaired respiration. Hence, targeting the mitochondria with drugs offers great potential for new therap… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

0
40
0

Year Published

2013
2013
2021
2021

Publication Types

Select...
8
2

Relationship

0
10

Authors

Journals

citations
Cited by 64 publications
(40 citation statements)
references
References 64 publications
0
40
0
Order By: Relevance
“…Here, we propose that epoxy-␣-lapachone is able to act in any metabolic pathway by compromising the ⌬ m of intracellular (primarily mitochondrial) organelles, as revealed by reductions in TMRE staining. The collapse of the mitochondrial transmembrane potential is related to the opening of mitochondrial permeability pores, leading to the release of cytochrome c into the cytosol, which then leads to other events in the apoptotic cascade (39).…”
Section: Discussionmentioning
confidence: 99%
“…Here, we propose that epoxy-␣-lapachone is able to act in any metabolic pathway by compromising the ⌬ m of intracellular (primarily mitochondrial) organelles, as revealed by reductions in TMRE staining. The collapse of the mitochondrial transmembrane potential is related to the opening of mitochondrial permeability pores, leading to the release of cytochrome c into the cytosol, which then leads to other events in the apoptotic cascade (39).…”
Section: Discussionmentioning
confidence: 99%
“…Mitochondrial therapies, particularly those involving mitochondria-targeted antioxidants, have been considered to be effective in treating cancer7, 35. In this study, a TPP carrier was used to target HCAs to mitochondria.…”
Section: Discussionmentioning
confidence: 99%
“…The only noncoding region of mtDNA is a small regulatory region (∼5% of the genome) with critical elements for transcription (promoters for both strands) and replication (origin of replication). Because mtDNA is essential for mitochondria (Chinnery and Hudson, 2013), its targeting with drugs offers potential for new therapeutics, as well as molecular tools to study mtDNA homeostasis and their effects on mitochondria (Rowe et al, 2001;Neuzil et al, 2013;Olszewska and Szewczyk, 2013).…”
Section: Introductionmentioning
confidence: 99%